Anuh Pharma has announced a bonus issue in the ratio of 1: 1, which has an X-date today. The company’s shares rose 0.89 per cent to close at Rs 207.75 a day before. This corporate action has caught attention to stock, which has a market capitalization of Rs 520.56 crore.
1: 1 bonus issue means that according to the shares that shareholders have currently, they will be given a shares on every stock free. X-det, that is, if someone bought the stock after that date, he will not get a bonus share. The X date of Anuh Pharma today is July 15, 2025. This date is important for investors who want to be entitled to bonuses.
Investigating the financial performance of Anuh Pharma, the company recorded a sales of Rs 661 crore for the end of March 2025, compared to Rs 647 crore in the previous year. The other income was Rs 9 crore, causing the total income to Rs 670 crore. The total expenditure for the same period was Rs 609 crore, resulting in an Ebit of Rs 61 crore. The net profit for the year ended March 2025 was Rs 47 crore.
| Metric | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Sales | 661 | 647 | 527 | 486 | 431 |
| Other income | 9 | 12 | 6 | 5 | 10 |
| Total income | 670 | 659 | 533 | 491 | 442 |
| Total expenditure | 609 | 580 | 485 | 451 | 402 |
| EBIT | 61 | 78 | 47 | 40 | 40 |
| Interest | 0 | 0 | 0 | 0 | 1 |
| Tax | 13 | 18 | 11 | 8 | 10 |
| Net profit | 47 | 60 | 36 | 30 | 28 |
The quarter result of the company shows sales of Rs 198 crore for March 2025, while in December 2024 it was Rs 159 crore. The net profit for this quarter was Rs 12 crore.
| Metric | March 2025 | December 2024 | September 2024 | June 2024 | March 2024 |
|---|---|---|---|---|---|
| Sales | 198 | 159 | 165 | 137 | 163 |
| Other income | 1 | 0 | 3 | 3 | 2 |
| Total income | 199 | 160 | 169 | 141 | 166 |
| Total expenditure | 182 | 146 | 150 | 129 | 146 |
| EBIT | 17 | 13 | 18 | 12 | 19 |
| Interest | 0 | 0 | 0 | 0 | 0 |
| Tax | 4 | 2 | 3 | 2 | 4 |
| Net profit | 12 | 10 | 15 | 9 | 15 |
In addition, the company’s cash flow was Rs 37 crore from operating activities for the end of March 2025, while the investment activities resulted in cash outflow of Rs 19 crore, and outflow of Rs 4 crore was seen in finance activities.
The balance sheet shows that by March 2025, Anuh Pharma has a share capital of Rs 25 crore and Reserve and Surplus Rs 300 crore. The total liabilities of the company are Rs 506 crore, while the total assets are Rs 506 crore.
The main financial ratio shows basic EPS of Rs 9.45 and book value of Rs 65.06 per share for the year ended on March 2025. Dividend was Rs 1.50 per share. The company’s board has recommended this bonus to reward shareholders.